Table of Contents Author Guidelines Submit a Manuscript
Arthritis
Volume 2014, Article ID 782850, 7 pages
http://dx.doi.org/10.1155/2014/782850
Research Article

Epicardial Fat Thickness as Cardiovascular Risk Factor and Therapeutic Target in Patients with Rheumatoid Arthritis Treated with Biological and Nonbiological Therapies

1Division of Medical Physiology, Department of Physiological Sciences, University of Oriente, Ciudad Bolívar 8001, Venezuela
2Endocrinology, Diabetes, Metabolism and Nutrition Unit, Orinoco Medical Center, Annex A. Siegert Avenue, Ciudad Bolívar 8001, Venezuela
3Endocrinology Unit, University Hospital of Los Andes, Mérida 5101, Venezuela
4Rheumatology Service, Ruiz y Paez University Hospital, Ciudad Bolívar 8001, Venezuela
5Cardiology Service, Ruiz y Paez University Hospital, Ciudad Bolívar 8001, Venezuela
6El Valle Medical Center, Nueva Esparta 6301, Venezuela
7Intensive Coronary Care Unit, Hospital Manuel Fajardo, 10400 Havana, Cuba
8Division of Endocrinology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA

Received 17 August 2014; Revised 23 November 2014; Accepted 24 November 2014; Published 10 December 2014

Academic Editor: George D. Kitas

Copyright © 2014 Marcos M. Lima-Martínez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. P. Liao and D. H. Solomon, “Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis,” Rheumatology, vol. 52, no. 1, pp. 45–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Adhikari, A. Guin, S. Chakraborty, P. Sinhamahapatra, and A. Ghosh, “Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study,” Seminars in Arthritis and Rheumatism, vol. 41, no. 5, pp. 669–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. P. Chung, A. Oeser, P. Raggi et al., “Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3045–3053, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Weinblatt, J. M. Kremer, A. D. Bankhurst et al., “A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate,” The New England Journal of Medicine, vol. 340, no. 4, pp. 253–259, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Keystone, M. C. Genovese, L. Klareskog et al., “Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 1129–1135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. H. Solomon, J. R. Curtis, K. G. Saag et al., “Cardiovascular risk in rheumatoid arthritis: comparing tnf-α blockade with nonbiologic DMARDs,” The American Journal of Medicine, vol. 126, no. 8, pp. 730.e9–730.e17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Lima-Martínez, C. Blandenier, and G. Iacobellis, “Epicardial adipose tissue: more than a simple fat deposit?” Endocrinologia y Nutricion, vol. 60, no. 6, pp. 320–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Iacobellis and H. J. Willens, “Echocardiographic epicardial fat: a review of research and clinical applications,” Journal of the American Society of Echocardiography, vol. 22, no. 12, pp. 1311–1319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Iacobellis and A. C. Bianco, “Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features,” Trends in Endocrinology and Metabolism, vol. 22, no. 11, pp. 450–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Iacobellis, “Epicardial adipose tissue in endocrine and metabolic diseases,” Endocrine, vol. 46, no. 1, pp. 8–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. D. Pierdomenico, A. M. Pierdomenico, F. Cuccurullo, and G. Iacobellis, “Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome,” American Journal of Cardiology, vol. 111, no. 1, pp. 73–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Ormseth, A. Lipson, N. Alexopoulos et al., “Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis,” Arthritis Care and Research, vol. 65, no. 9, pp. 1410–1415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2569–2581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Iacobellis, F. Assael, M. C. Ribaudo et al., “Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction,” Obesity Research, vol. 11, no. 2, pp. 304–310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. B. Devereux, D. R. Alonso, and E. M. Lutas, “Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings,” The American Journal of Cardiology, vol. 57, no. 6, pp. 450–458, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Gabriel and C. S. Crowson, “Risk factors for cardiovascular disease in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 24, no. 2, pp. 171–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. T.-B. Nguyen-Duy, M. Z. Nichaman, T. S. Church, S. N. Blair, and R. Ross, “Visceral fat and liver fat are independent predictors of metabolic risk factors in men,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 284, no. 6, pp. E1065–E1071, 2003. View at Google Scholar · View at Scopus
  18. G. Iacobellis, M. C. Ribaudo, F. Assael et al., “Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 11, pp. 5163–5168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Torres, M. M. Lima-Martínez, F. J. Rosa, E. Guerra, M. Paoli, and G. Iacobellis, “Epicardial adipose tissue and its association to plasma adrenomedullin levels in patients with metabolic syndrome,” Endocrinología y Nutrición, vol. 58, pp. 401–408, 2011. View at Google Scholar
  20. L. Fardet, J. Cabane, A. Kettaneh, C. Lebbé, and A. Flahault, “Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome,” Rheumatology, vol. 46, no. 7, pp. 1102–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Walsmith and R. Roubenoff, “Cachexia in rheumatoid arthritis,” International Journal of Cardiology, vol. 85, no. 1, pp. 89–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Šenolt, M. Kuklová, L. A. Cerezo et al., “Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 11, pp. 2054–2056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. D. Renzo, R. Saraceno, C. Schipani et al., “Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment,” Dermatologic Therapy, vol. 24, no. 4, pp. 446–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Y. Chau, R. Bandiera, A. Serrels et al., “Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source,” Nature Cell Biology, vol. 16, no. 4, pp. 367–375, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Porter, J. M. Massaro, U. Hoffmann, R. S. Vasan, C. J. O'Donnel, and C. S. Fox, “Abdominal subcutaneous adipose tissue: a protective fat depot?” Diabetes Care, vol. 32, no. 6, pp. 1068–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Mookadam, R. Goel, M. S. Alharthi, P. Jiamsripong, and S. Cha, “Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study,” Heart Views, vol. 11, pp. 103–108, 2010. View at Google Scholar
  27. A. R. Baker, A. L. Harte, N. Howell et al., “Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 261–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. N. Lumeng, S. M. Deyoung, and A. R. Saltiel, “Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins,” American Journal of Physiology: Endocrinology and Metabolism, vol. 292, no. 1, pp. E166–E174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish, “Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNF-α is obligatory,” Diabetes, vol. 51, no. 5, pp. 1319–1336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Xie, M. T. Ortega, S. Mora, and S. K. Chapes, “Interactive changes between macrophages and adipocytes,” Clinical and Vaccine Immunology, vol. 17, no. 4, pp. 651–659, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. B. Goldfine, V. Fonseca, K. A. Jablonski et al., “Salicylate (Salsalate) in patients with type 2 diabetes: a randomized trial,” Annals of Internal Medicine, vol. 159, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Bartoloni, Y. Shoenfeld, and R. Gerli, “Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin,” Arthritis Care & Research, vol. 63, no. 2, pp. 178–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Lipson, N. Alexopoulos, G. R. Hartlage et al., “Epicardial adipose tissue is increased in patients with systemic lupus erythematosus,” Atherosclerosis, vol. 223, no. 2, pp. 389–393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. G. Semb, S. Rollefstad, S. A. Provan et al., “Carotid plaque characteristics and disease activity in rheumatoid arthritis,” Journal of Rheumatology, vol. 40, no. 4, pp. 359–368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. L. Rudominer, M. J. Roman, R. B. Devereux et al., “Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 22–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Sun, M. Chen, F. Dawood et al., “Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state,” Circulation, vol. 115, no. 11, pp. 1398–1407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Iacobellis, M. C. Ribaudo, A. Zappaterreno, C. V. Iannucci, and F. Leonetti, “Relation between epicardial adipose tissue and left ventricular mass,” American Journal of Cardiology, vol. 94, no. 8, pp. 1084–1087, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. A. E. Malavazos, G. di Leo, F. Secchi et al., “Relation of echocardiographic epicardial fat thickness and myocardial fat,” American Journal of Cardiology, vol. 105, no. 12, pp. 1831–1835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Mazurek, L. Zhang, A. Zalewski et al., “Human epicardial adipose tissue is a source of inflammatory mediators,” Circulation, vol. 108, no. 20, pp. 2460–2466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. G. F. Mureddu, R. Greco, G. F. Rosato et al., “Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity,” International Journal of Obesity, vol. 22, no. 4, pp. 363–368, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. E. N. Pollono, M. A. Lopez-Olivo, J. A. M. Lopez, and M. E. Suarez-Almazor, “A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis,” Clinical Rheumatology, vol. 29, no. 9, pp. 947–955, 2010. View at Publisher · View at Google Scholar · View at Scopus